脂肪肝
甲状腺
脂肪生成
激素
内分泌学
血脂异常
甲状腺激素受体
内科学
医学
甲状腺激素受体β
脂肪酸代谢
β氧化
脂质代谢
激素受体
新陈代谢
疾病
癌症
乳腺癌
作者
Lorraine Soares De Oliveira,Megan Ritter
标识
DOI:10.1097/hc9.0000000000000596
摘要
It is known that thyroid hormone can regulate hepatic metabolic pathways including cholesterol, de novo lipogenesis, fatty acid oxidation, lipophagy, and carbohydrate metabolism. Thyroid hormone action is mediated by the thyroid hormone receptor (THR) isoforms and their coregulators, and THRβ is the main isoform expressed in the liver. Dysregulation of thyroid hormone levels, as seen in hypothyroidism, has been associated with dyslipidemia and metabolic dysfunction-associated fatty liver disease. Given the beneficial effects of thyroid hormone in liver metabolism and the advances illuminating the use of thyroid hormone analogs such as resmetirom as therapeutic agents in the treatment of metabolic dysfunction-associated fatty liver disease, this review aims to further explore the relationship between TH, the liver, and metabolic dysfunction-associated fatty liver disease. Herein, we summarize the current clinical therapies and highlight future areas of research.
科研通智能强力驱动
Strongly Powered by AbleSci AI